Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Gastrointestinal Stromal Tumors × regorafenib × Clear all

Phase

Phase 2 6 Phase 4 1 Phase 3 1 Phase 2/3 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Gastrointestinal 1

Conditions

Sarcoma, Ewing 1 Recurrence 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Colorectal Neoplasms 1 Asian Colorectal Cancer Patients 1

Interventions

regorafenib 1 Imatinib Mesylate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07379047 2026-01-30

GISTAR-1

Ningbo Newbay Technology Development Co., Ltd

Phase 2/3 Not yet recruiting

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡